{"id":"https://openalex.org/W1809024175","doi":null,"title":"Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.","display_name":"Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.","alternate_titles":[],"publication_year":1996,"publication_date":"1996-02-01","ids":{"openalex":"https://openalex.org/W1809024175","mag":"1809024175","pmid":"https://pubmed.ncbi.nlm.nih.gov/8564971"},"language":"en","primary_location":{"id":"pmid:8564971","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8564971","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Comparative Study"},"parent_works":[],"lineage":["https://openalex.org/W1809024175"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048820442","display_name":"Paola Perego","orcid":"https://orcid.org/0000-0003-2806-7269","observed_orcids":["https://orcid.org/0000-0003-2806-7269"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P Perego","raw_affiliation_strings":["Division of Experimental Oncology, Istituto Nazionale Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Experimental Oncology, Istituto Nazionale Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052204789","display_name":"Monica Giarola","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Giarola","raw_affiliation_strings":["Istituto Nazionale Ricerca Cancer, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Ricerca Cancer, Milan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080261722","display_name":"Sabina Carla Righetti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S C Righetti","raw_affiliation_strings":["Istituto Nazionale Ricerca Cancer, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Ricerca Cancer, Milan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041620597","display_name":"Rosanna Supino","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R Supino","raw_affiliation_strings":["Istituto Nazionale Ricerca Cancer, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Ricerca Cancer, Milan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070863361","display_name":"Claudia Caserini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C Caserini","raw_affiliation_strings":["Istituto Nazionale Ricerca Cancer, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Ricerca Cancer, Milan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110859572","display_name":"Domenico Delia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D Delia","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002696649","display_name":"Marco Alessandro Pierotti","orcid":"https://orcid.org/0000-0002-7431-8332","observed_orcids":["https://orcid.org/0000-0002-7431-8332"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M A Pierotti","raw_affiliation_strings":["Istituto Nazionale Ricerca Cancer, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Ricerca Cancer, Milan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033689092","display_name":"Toshiyuki Miyashita","orcid":"https://orcid.org/0000-0002-0929-4629","observed_orcids":["https://orcid.org/0000-0002-0929-4629"]},"institutions":[{"id":"https://openalex.org/I188891513","display_name":"Sanford Burnham Prebys Medical Discovery Institute","ror":"https://ror.org/03m1g2s55","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I188891513"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T Miyashita","raw_affiliation_strings":["Sanford-Burnham-Prebys Medical Discovery Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanford-Burnham-Prebys Medical Discovery Institute","institution_ids":["https://openalex.org/I188891513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104094400","display_name":"John C. Reed","orcid":"https://orcid.org/0009-0001-5364-3566","observed_orcids":["https://orcid.org/0009-0001-5364-3566"]},"institutions":[{"id":"https://openalex.org/I188891513","display_name":"Sanford Burnham Prebys Medical Discovery Institute","ror":"https://ror.org/03m1g2s55","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I188891513"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J C Reed","raw_affiliation_strings":["Sanford-Burnham-Prebys Medical Discovery Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanford-Burnham-Prebys Medical Discovery Institute","institution_ids":["https://openalex.org/I188891513"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033312783","display_name":"Franco Zunino","orcid":"https://orcid.org/0000-0002-1895-2742","observed_orcids":["https://orcid.org/0000-0002-1895-2742"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F Zunino","raw_affiliation_strings":["Istituto Nazionale Ricerca Cancer, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Ricerca Cancer, Milan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":17.0224,"has_fulltext":false,"cited_by_count":445,"citation_normalized_percentile":{"value":0.99405617,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"56","issue":"3","first_page":"556","last_page":"562"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.9526000022888184,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.9526000022888184,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.03689999878406525,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cisplatin-resistance","display_name":"cisplatin resistance","score":0.9929999709129333},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9269999861717224},{"id":"https://openalex.org/keywords/bax-expression","display_name":"Bax expression","score":0.7889999747276306},{"id":"https://openalex.org/keywords/ovarian-carcinoma","display_name":"ovarian carcinoma","score":0.9710000157356262},{"id":"https://openalex.org/keywords/p53-dna-binding-domain","display_name":"p53 DNA-binding domain","score":0.7490000128746033},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6819999814033508},{"id":"https://openalex.org/keywords/ionizing-radiation-resistance","display_name":"ionizing radiation resistance","score":0.7599999904632568},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.6399999856948853},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.7170000076293945},{"id":"https://openalex.org/keywords/p53-protein-levels","display_name":"p53 protein levels","score":0.5299999713897705}],"concepts":[{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.743367075920105},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5568997263908386},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.5468451976776123},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5275471210479736},{"id":"https://openalex.org/C36823959","wikidata":"https://www.wikidata.org/wiki/Q373027","display_name":"Exon","level":3,"score":0.5249141454696655},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4401729106903076},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3969743847846985},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2995394468307495},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.09354755282402039}],"mesh":[{"descriptor_ui":"D001483","descriptor_name":"Base Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004249","descriptor_name":"DNA Damage","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011401","descriptor_name":"Promoter Regions, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015152","descriptor_name":"Blotting, Northern","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015500","descriptor_name":"Chloramphenicol O-Acetyltransferase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015533","descriptor_name":"Transcriptional Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016158","descriptor_name":"Genes, p53","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D016213","descriptor_name":"Cyclins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017930","descriptor_name":"Genes, Reporter","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018807","descriptor_name":"Polymorphism, Single-Stranded Conformational","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D050759","descriptor_name":"Cyclin-Dependent Kinase Inhibitor p21","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051028","descriptor_name":"bcl-2-Associated X Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:8564971","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8564971","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Comparative Study"},{"id":"mag:1809024175","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8564971","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8560000061988831,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G530399882","display_name":"MECHANISMS ONCOGONE ACTIVATION AND FUNCTION--BCL3 TCL5","funder_award_id":"R01CA060181","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W35717447","https://openalex.org/W994887766","https://openalex.org/W1498586399","https://openalex.org/W1518376386","https://openalex.org/W1552426876","https://openalex.org/W1583547469","https://openalex.org/W1654947539","https://openalex.org/W1977686001","https://openalex.org/W1987437563","https://openalex.org/W2004969496","https://openalex.org/W2016859145","https://openalex.org/W2026456619","https://openalex.org/W2043912950","https://openalex.org/W2070461153","https://openalex.org/W2074598863","https://openalex.org/W2078003307","https://openalex.org/W2078144803","https://openalex.org/W2078988395","https://openalex.org/W2081894694","https://openalex.org/W2092200570","https://openalex.org/W2100837269","https://openalex.org/W2103936018","https://openalex.org/W2127952872","https://openalex.org/W2134979684","https://openalex.org/W2158874806","https://openalex.org/W2339809149","https://openalex.org/W2397241885","https://openalex.org/W2399587269","https://openalex.org/W2413760962","https://openalex.org/W2417643957","https://openalex.org/W2433711353","https://openalex.org/W3121869049"],"related_works":["https://openalex.org/W1991191453","https://openalex.org/W2166541959","https://openalex.org/W2004969496","https://openalex.org/W2211647308","https://openalex.org/W2071718763","https://openalex.org/W1999555525","https://openalex.org/W1519618894","https://openalex.org/W2152695103","https://openalex.org/W1973201819","https://openalex.org/W1515524431"],"abstract_inverted_index":{"P53":[0],"status":[1,37],"may":[2],"be":[3],"a":[4,77,108,248,264,286,322,340],"determinant":[5],"of":[6,8,30,62,79,81,120,126,161,179,198,213,251,299,307,311,326,333,342,344,347],"chemosensitivity":[7],"tumor":[9],"cells;":[10],"however,":[11],"its":[12],"involvement":[13],"in":[14,40,56,133,139,165,184,187,206,219,229,255,267,271,309,314,330,336],"cellular":[15],"resistance":[16,31,80,335],"to":[17,32,90,96,105,112,141,192,296,349],"cisplatin":[18,106,334],"remains":[19],"uncertain.":[20],"To":[21],"investigate":[22],"the":[23,28,34,63,91,124,134,142,149,158,166,199,207,211,220,230,242,292,305,327,331,345],"relationships":[24],"between":[25],"p53":[26,35,151,180,200,282,308,328,348],"and":[27,52,71,84,93,102,173,257,285],"development":[29,332],"cisplatin,":[33,196],"gene":[36,288,294,329],"was":[38,202,216],"studied":[39],"ovarian":[41,337],"carcinoma":[42],"cell":[43,67,74,110,137,145,252],"systems":[44],"which":[45,147],"included":[46],"two":[47,127,135,162],"cisplatin-resistant":[48,274],"variants":[49],"(IGROV-1/Pt":[50],"0.5":[51,70],"IGROV-1/Pt":[53,69,72,188,231,272],"1)":[54],"selected":[55],"vitro":[57],"after":[58,234],"prolonged":[59],"drug":[60,92],"exposure":[61,89,191],"cisplatin-sensitive":[64],"parental":[65,143,221],"IGROV-1":[66,144,185,222],"line.":[68],"1":[73,232,273],"lines":[75],"exhibited":[76,148],"degree":[78],"approximately":[82],"6":[83],"14,":[85],"respectively,":[86],"following":[87],"96-h":[88],"were":[94,182,302],"cross-resistant":[95],"other":[97],"DNA-damaging":[98,235],"agents":[99],"(ionizing":[100],"radiation":[101,194,246],"melphalan).":[103],"Resistance":[104],"paralleled":[107],"reduced":[109],"susceptibility":[111],"cisplatin-induced":[113],"apoptosis.":[114],"DNA":[115,154],"single-strand":[116],"conformation":[117],"polymorphism":[118],"analysis":[119,262],"exons":[121],"5-9":[122],"demonstrated":[123,263],"presence":[125],"mutants":[128],"alleles":[129],"at":[130,169],"exon":[131],"8":[132],"resistant":[136,258],"lines,":[138],"contrast":[140],"line":[146],"wild-type":[150,279],"gene.":[152,354],"Direct":[153],"sequencing":[155],"revealed":[156],"that":[157,244,290],"mutations":[159,325],"consist":[160],"nucleotide":[163],"changes":[164],"DNA-binding":[167],"domain":[168],"codons":[170],"270":[171],"(T/A)":[172],"282":[174],"(C/T).":[175],"The":[176],"consecutive":[177],"levels":[178,270],"protein":[181,201,215,226],"lower":[183],"than":[186],"cells.":[189,209,259,275,316],"Following":[190],"ionizing":[193,245],"or":[195,280],"accumulation":[197],"markedly":[203],"enhanced":[204],"only":[205],"sensitive":[208,256],"Concomitantly,":[210],"expression":[212,283,313],"WAF-1":[214,225],"strongly":[217],"induced":[218],"cells,":[223],"whereas":[224],"remained":[227],"undetectable":[228],"subline":[233],"treatment.":[236],"Consistent":[237],"with":[238,278,304],"this":[239],"finding":[240],"is":[241],"observation":[243],"caused":[247],"different":[249],"pattern":[250],"cycle":[253],"perturbation":[254],"Northern":[260],"blot":[261],"marked":[265],"reduction":[266],"bax":[268,293,312],"mRNA":[269],"Cotransfection":[276],"assays":[277],"mutant":[281],"plasmids":[284],"reporter":[287],"plasmid":[289],"utilized":[291],"promoter":[295],"drive":[297],"transcription":[298],"chloramphenicol":[300],"acetyltransferase":[301],"consistent":[303],"role":[306,323],"regulation":[310],"these":[315,319],"Taken":[317],"together,":[318],"observations":[320],"support":[321],"for":[324],"cancer":[338],"as":[339],"consequence":[341],"loss":[343],"ability":[346],"transactivate":[350],"bax,":[351],"an":[352],"apoptosis-inducing":[353]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1809024175","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":16},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
